Remdesivir for COVID-19
On May 1, 2020, the FDA authorized the emergency use of Remdesivir for COVID-19. This was based on a preliminary analysis of an NIH clinical trial. However, information is still lacking on safety and efficacy in a larger study population. In this session, we will review the known mechanism of action of this novel antiviral medication and limitations of data.
You May Also Like
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Feldman Protocol
Dave Feldman
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
The 365 Days of Astronomy
365DaysOfAstronomy.org
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Breaking Down: Collapse
Kory & Kellan
The Biotech Startups Podcast
Excedr
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Feldman Protocol
Dave Feldman
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
The 365 Days of Astronomy
365DaysOfAstronomy.org
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Breaking Down: Collapse
Kory & Kellan
The Biotech Startups Podcast
Excedr
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
Community discussion